For a menopause-related search, choose a source category below. These categories also contain products for other uses; they are not a list of suitable treatments.
HORMONES AND SUBSTITUTES
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
DROSPIRENONE & ETHINYL ESTRADIOL: products 1 to 9 of 9.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Drospirenone&Ethinyl Estradiol USP 3.0mg & 0.02mg Tab-28 PkDIN 02462060 | General benefit | $8.2600per source unit | Requirements & sourcesBuild cost plan |
| Drospirenone&Ethinyl Estradiol USP 21 3.0mg & 0.03mg Tab-21 PkDIN 02421437 | General benefit | $6.2181per source unit | Requirements & sourcesBuild cost plan |
| Drospirenone&Ethinyl Estradiol USP 28 3.0mg & 0.03mg Tab-28 PkDIN 02421445 | General benefit | $6.2188per source unit | Requirements & sourcesBuild cost plan |
| MYA 3.0mg & 0.02mg Tab-28 PkDIN 02415380 | General benefit | $8.2600per source unit | Requirements & sourcesBuild cost plan |
| Yasmin 21 3.0mg & 0.03mg Tab-21 PkDIN 02261723 | General benefit | $6.2181per source unit | Requirements & sourcesBuild cost plan |
| Yasmin 28 3.0mg & 0.03mg Tab-28 PkDIN 02261731 | General benefit | $6.2188per source unit | Requirements & sourcesBuild cost plan |
| Yaz 3.0mg & 0.02mg Tab-28 PkDIN 02321157 | General benefit | $8.2600per source unit | Requirements & sourcesBuild cost plan |
| Zamine 21 3.0mg & 0.03mg Tab-21 PkDIN 02410788 | General benefit | $6.2181per source unit | Requirements & sourcesBuild cost plan |
| Zamine 28 3.0mg & 0.03mg Tab-28 PkDIN 02410796 | General benefit | $6.2188per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:00 HORMONES AND SUBSTITUTES.
68:04 Corticosteroids.
68:08 Androgens.
68:12 Contraceptives.
68:16 Estrogens.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).
68:24 Parathyroid Agents.
68:28 Pituitary Agents.
68:32 Progestogens and Oral Contraceptives.
68:36 Thyroids.
68:38 Anti-Thyroids.
National Defence, WDH Guide to Menopause, 2026-09-17
Hormone Therapy (HT) previously called Hormone Replacement Therapy replaces estrogen and when needed, progesterone
Ontario Drug Benefit Formulary, Part V, 2026-09-03, p. 38
68:16 Estrogens
68:32 Progestogens and Oral Contraceptives